Clinical trial
Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)
NCT00000517 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00000517 |
|---|---|
| Title | Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF) |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Arrhythmia, Atrial Fibrillation, Cardiovascular Diseases, Cerebral Embolism and Thrombosis, Cerebrovascular Disorders, Heart Diseases, Thrombophlebitis, Cerebrovascular Accident |
| Intervention type | Drug |
| Interventions | warfarin |
| Start date | Jul 1, 1985 |
| Primary completion | Jun 1, 1991 |
| Completion | Jun 1, 1991 |
| First posted | Oct 28, 1999 |
| Last update posted | Apr 10, 2014 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: